Olmesartan medoxomil
What is Olmesartan medoxomil?
Olmesartan medoxomil (CAS 144689-63-4) is an angiotensin II receptor blocker (ARB) prodrug used as an active pharmaceutical ingredient in antihypertensive formulations. Also marketed as Benicar and Olmetec.
Where is Olmesartan medoxomil used?
- Oral tablets for hypertension
- Standalone or combination products, commonly paired with amlodipine or hydrochlorothiazide
- Generic drug manufacturers develop bioequivalent products
- CDMOs use it in formulation development projects requiring ICH-compliant API characterization
- Pharmaceutical importers and distributors source it for regulated markets requiring DMF or CEP documentation support
Good to know: Developed under the research code CS-866. Sourcing typically follows patent expiry in key regulated markets.
Commercial specifications
- Pharmaceutical-grade specifications aligned with USP, BP, and Ph. Eur. monographs
- Standard commercial pack sizes range from small quantities for R&D use to bulk quantities for commercial manufacturing batches
Other Names (Synonyms)
Benicar|Olmetec|CS-866|6M97XTV3HD|1,3-Dioxole, 1H-imidazole-5-carboxylic acid deriv.